PMEF
EW icon

Point72 Middle East FZE’s Edwards Lifesciences EW Stock Holding History

Point72 Middle East FZE’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-12,600
Closed -$961K – 463
2023
Q4 		$961K Buy
12,600
+9,200
+271% +$640K 0.03% 629
2023
Q3 		$236K Buy
3,400
+1,100
+48% +$88.4K 0.01% 990
2023
Q2 		$217K Sell
2,300
-10,300
-82% -$895K 0.01% 1035
2023
Q1 		$1.04M Sell
12,600
-1,400
-10% -$110K 0.04% 488
2022
Q4 		$1.04M Buy
+14,000
New +$1.08M 0.05% 491

Other funds holding EW

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Point72 Middle East FZE's EW Position: Q4 2023 in Review

Point72 Middle East FZE sold out of Edwards Lifesciences (EW) in Q4 2023, closing a stake of 21,693 shares — an estimated $1.51M sold.

Point72 Middle East FZE first reported a position in EW in Q4 2022 and held it in 2 quarters. The position peaked at $1.5M in Q3 2023. 1,244 funds tracked by Wall St. Rank hold EW as of Q4 2023.

  • Point72 Middle East FZE reported no remaining Edwards Lifesciences position as of Q4 2023 after selling out during the quarter.
  • Point72 Middle East FZE sold 21,693 Edwards Lifesciences shares in Q4 2023, an estimated $1.51M.
  • Point72 Middle East FZE first reported a position in Edwards Lifesciences in Q4 2022 and held it in 2 quarters.
  • Point72 Middle East FZE's Edwards Lifesciences position peaked at $1.5M in Q3 2023.
  • 1,244 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q4 2023.

Based on Point72 Middle East FZE's 13F filing for Q4 2023, filed 14 Feb 2024.